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Abstract
Background: Reactive oxygen species (ROS) are closely associated with the intracellular signal
cascade, thus strongly implicating involvement in tumor progression. However, the mechanism by
which ROS are generated and how ROS target downstream molecules to trigger tumor metastasis
is unclear. In this study, we investigated the underlying signal pathways in ROS-induced urokinase
plasminogen activator (uPA) expression in the human gastric cancer cells, NUGC-3 and MKN-28.
Methods and Results: Intracellular ROS, as determined using the fluorescent probe, 2'-7'
dichlorofluorescein diacetate, decreased after treatment with hepatocyte growth factor (HGF).
We confirmed that Rac-1 regulated ROS production after activation of the AKT pathway with
HGF. Exogenously added H2O2 promoted the expression of HGF, but not in a dose-dependent
manner and also showed negative expression of HGF after co-treatment with H2O2 and HGF.
Treatment with NAC, an intracellular free radical scavenger, decreased the enhancement of uPA
production and tumor invasion in both cells. We clarified the downstream pathways regulated by
ROS after treatment with H2O2, which showed negative control between FRK and p38 kinase
activities for uPA regulation.
Conclusion: HGF regulates Rac-1-induced ROS production through the Akt pathway and ROS
regulates uPA production and invasion via MAP kinase, which provides novel insight into the
mechanisms underlying the progression of gastric cancer.
Background
Gastric cancer is the second most common cause of cancer
death worldwide despite of the improved prognosis. To
understand the precise mechanisms underlying invasion
and metastasis would be helpful in improving survival.
ROS, such as superoxide anion (O2-), hydrogen peroxide
(H2O2), and hydroxyl radical (HO-), have emerged as
highly toxic agents responsible for a wide variety of tissue
damage [1] The involvement of these ROS in the patho-
genesis of gastric diseases first became evident from the
study of gastric mucosal injuries under normal condi-
tions. ROS are relatively harmless, but when produced
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oxidant and antioxidant balance is disturbed and the
metabolites become toxic, which may lead to the initia-
tion and promotion of cancer [2]. However, despite the
positive correlation between the increased generation of
ROS and the invasion of cancer, the specific mechanisms
by which antioxidants act to suppress cancer development
through ROS is unknown.
HGF has multiple biologic effects on a wide variety of
cells, including mitogenic, motogenic, morphogenic, and
anti-apoptotic activities [3,4]. The receptor for HGF is c-
Met, a proto-oncogene product. Overexpression and
mutation of the c-Met receptor has been well-described in
various cancers [5,6]. Some studies have reported that
HFG stimulates the migration and invasiveness of trans-
formed epithelial cells concomitantly with the up-regula-
tion of uPA [7]. In a separate study, HGF/c-Met signaling
enhanced gastric cancer cell proliferation and increased
uPA synthesis and activity. Inhibition of uPA receptors by
monoclonal antibody against the uPA receptor decreased
tumor cell invasion. Mitogen-activated protein kinase
(MAPK) transduces extracellular signals into cellular
responses, and thus plays an important role in prolifera-
tion, apoptosis, differentiation, and migration [8,9].
Gupta et al. [10] reported that increased ROS levels
enhance MAP kinase activity for malignant progression of
mouse keratinocyte cell lines.
In this study, we found that HGF modulates Rac-1-regu-
lated ROS production, ROS induces the expression of uPA
via the MAPK pathway, and stimulates the invasiveness of
human gastric cancer cells.
Methods
Cell cultures
Two human gastric cancer cell lines (a poorly differenti-
ated adenocarcinoma [NUGC-3] and a moderately differ-
entiated tubular adenocarcinoma [MKN-28]), which were
obtained from the Korea Cell Line Bank (Seoul, Korea),
were used in the experiments described herein. Cells were
maintained in Dulbecco's modified Eagle's medium
(DMEM) supplemented with 10% fetal bovine serum, 1
mM sodium pyruvate, 0.1 mM non-essential amino acids,
2 mM L-glutamine, a 2-fold vitamin solution, and 50 U/
ml penicillin/streptomycin (Life Technologies, Inc.,
Gaithersburg, MD, USA) in an incubator under a humidi-
fied atmosphere of 5% CO2 and 95% air at 37°C. Unless
otherwise noted, cells were passaged and removed at 70%
to 80% confluency.
Reagents and antibodies
Antibodies against ERK, p38, phospho-ERK, and phos-
pho-p38 were purchased from Cell Signaling Technology
(Beverly, Massachusetts, USA). Antibodies against AKT,
phosphor-AKT, and Rac1 were obtained from Santa Cruz
Biotechnology, Inc. (Santa Cruz, California, USA). N-ace-
tylcysteine (NAC), hydrogen peroxide (H2O2), and LY
294002 were purchased from Sigma (St. Louis, Missouri,
USA). 2'-7'-dichlorofluorescin diacetate (DCF-DA) was
obtained from Molecular Probes (Eugene, Oregon, USA).
Horseradish peroxidase-conjugated anti-mouse and anti-
rabbit antibodies were purchased from Bio-Rad Laborato-
ries (Philadelphia, Pennsylvania, USA). Recombinant
human HGF (R&D Systems, Inc, Minneapolis, Minnesota,
USA) and human uPA antibody (389; American Diagnos-
tica, Greenwich, Connecticut, USA) were also purchased.
A dominant positive Rac-1 (Q61L) plasmid was kindly
provided by Dr. K. Hahn of the university of North Caro-
lina.
Real-time PCR
Complementary DNA (cDNA) was synthesized from total
RNA using MMLV reverse transcriptase (Promega Corp.,
Madison, Wisconsin, USA) by the oligo (dT) priming
method in a 10 μl reaction mixture. Real-time PCR analy-
sis was performed using a lightCycler1.5 Instrument
(Roche, Mannheim, Germany). PCR was performed in a
LightCycler capillary in a 10 μl reaction volume that con-
tained 1* DNA Master SYBR Green I, 2.5 mM MgCI2, 1 μl
cDNA, and 0.4 uM primers. The PCR protocol was as fol-
lows: initial denaturation for 2 minutes at 95°C, 45 cycles
at 95°C for 10 seconds, 60°C for 5 seconds, and 72°C for
12 seconds. Results were analyzed with LightCycler Soft-
ware, version 3.5.3. Sequence-specific primers for HGF
were a forward primer, gggctgaaaagattggatca and a reverse
primer, ttgtattggtgggtgcttca.
Western blot analysis
Cells were harvested and incubated with a lysis buffer (50
mM Tris-HCl [pH 8.0], 150 mM NaCl, 1 mM EDTA, 1%
Trion X-100, 10% glycerol, 1 mM PMSF, 1 mM sodium
vanadate, and 5 mM NaF) with protease inhibitors and
centrifuged at 15,000 rpm at 4°C for 10 min. Proteins (50
μg) were separated on 10% SDS-polyacrylamide gels and
transferred to nitrocellulose membranes. The membranes
were soaked with 5% non-fat dried milk in 10 mM Tris-
HCl (pH 7.5), 150 mM NaCl, and 0.05% Tween-20
(TTBS) for 30 min and then incubated overnight with a
primary antibody at 4°C. After washing 6 times with TTBS
for 5 min, the membranes were incubated with a horse-
radish peroxidase-conjugated secondary antibody for 90
min at 4°C. The membranes were rinsed 3 times with
TTBS for 30 min and the antigen-antibody complex was
detected using the enhanced chemiluminescence detec-
tion system.
Measurement of Rac-1 activity
Rac-1 activity was measured using the Rac-1 activation kit
(Upstate Biotechnology, New York, USA). Briefly, whole-
protein extracts were immunoprecipitated with the pro-
tein binding domain of PAK-1 PBD. PAK-1 PBD onlyPage 2 of 9
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cipitated proteins were separated in SDS-polyacrylamide
gels and blotted with anti-Racl.
Measurement of ROS
ROS production was measured using the DCF-DA assay.
In brief, cells were seeded in 60 mm culture dishes at 70%
confluence and then starved in DMEM for 24 h. The cells
were treated with HGF (0, 10, or 40 ng/ml). After treat-
ment with HGF, cells were incubated with 10 μM of DCF-
DA for 10 min. The cells were harvested, washed once,
and resuspended in PBS. Fluorescence was monitored
using a flow cytometer (Becton-Dickinson, San Jose, Cali-
fornia, USA). The mean of the DCF fluorescence intensity
was obtained from 10000 cells using 480 nm excitation
and 540 nm emission settings. By using the same settings,
the fluorescent intensity was obtained from each experi-
mental group. Fluorescent levels were expressed as the
percentage increase over the control.
Standard two chamber invasion assay
Cells (1 × 104) and NAC (5 mM) were placed in the upper
chamber of a matrigel migration chamber with 0.8-
micron pores (Fisher Scientific, Houston, TX, USA).
Media containing 5% FBS and HGF (0 or 10 ng/mL), with
or without NAC (5 mM), was added to the bottom cham-
ber. After incubation for 48 hours, the cells were fixed and
stained using a HEMA 3 stain set (Curtis Matheson Scien-
tific, Houston, Texas, USA) according to the manufac-
turer's instruction. The stained filter membrane was cut
and placed on a glass slide. The migrated cells were
counted under light microscopy (10 fields at 200×
power).
Statistical analysis
The results of three independent experiments were
expressed as the means ± SD and were analyzed by Stu-
dent's t-test.
Results
HGF suppresses ROS generation in c-Met-overexpressing 
gastric cancer cells
The intracellular ROS levels in c-Met-overexpressing
NUGC-3 and MKN-28 cells treated with HGF were deter-
mined using DCF-DA by flow cytometry. Stimulation of c-
Met-overexpressing gastric cancer cells with HGF signifi-
cantly reduced the basal level of ROS in a dose-dependent
manner (Figure 1).
HGF suppresses Rac-1-regulated ROS production through 
activation of Akt
We examined the role of HGF in modulating ROS produc-
tion, particularly as regulated by Rac-1. Treatment with
HGF suppressed the basal activity of Rac-1 and increased
Rac-1 activity induced by H2O2 treatment (Figure 2A). In
addition, treatment with HGF suppressed also the Rac-1
activity increased in Rac-1 dominant positive cells (Figure
2B). Pretreatment of cells with LY 294002, a PI3-kinase
inhibitor, activated Rac-1 (Figure 3). Next, we examined
whether Akt is involved in the reduction of the ROS level
induced by HGF. Treatment of NUGC-3 and MKN-28
cells with HGF caused Akt activation in a dose-dependent
manner (Figure 4A) and pre-incubation of cells with LY
294002 reduced HGF-induced Akt phosphorylation (Fig-
ure 4B). Furthermore, inhibition of Akt by LY 294002
treatment increased the ROS levels. More importantly, the
effect of LY 294002 was abolished by HGF, as determined
using DCF-DA by flow cytometry (Figure 5). These results
suggest that PI3-kinase is an essential mediator through
which HGF inhibits ROS generation.
Upregulation of HGF mRNA levels in gastric cancer cell 
lines treated with H2O2
To understand the mechanism of uPA production of ROS,
we examined HGF gene expression using the RT-PCR
method. The levels of HGF mRNA were 1.7–2.4 fold
higher in cells treated with 100 μM H2O2 than in
untreated cells. However, HGF mRNA levels were
decreased when treated with 500 μM H2O2 (Figure 6).
This might be due to H2O2 cytotoxicity. Subsequently, we
measured HGF mRNA levels from both cell lines in the
absence or presence of exogenous HGF and/or H2O2. The
Effects of HGF on ROS accumulationFigure 1
Effects of HGF on ROS accumulation. Serum-starved 
cells were treated with increasing concentrations of HGF (0, 
10, and 40 ng/ml). After incubation for 1 h, the cells were 
incubated with DCF-DA (10 μM) for 10 min. The cells were 
washed with PBS, trypsinized, and resuspended in PBS. The 
intensity of DCF-fluorescence was immediately measured 
with a flow cytometer (A). Mean fluorescence intensity was 
obtained from 3 independent experiments and plotted (B). 
Representative data from 3 independent experiments were 
shown. Values are the means ± SD of three independent 
experiments. Statistical significance was estimated by Stu-
dent's t-test (*, p < 0.05).Page 3 of 9
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ment of HGF and H2O2 (Figure 7).
Effect of H2O2 and NAC on uPA production
uPA gradually accumulated in both cell lines after treat-
ment with HGF. Treatment with H2O2 resulted in an
increase in the uPA protein level in both cell lines. When
we treated cells with H2O2 and HGF, the uPA protein level
was decreased. To investigate the effect of N-acetylcysteine
(NAC), a precursor of glutathione and an intracellular free
radical scavenger, on HGF-induced uPA production, we
treated both cell lines with NAC. NAC decreased the HGF-
induced uPA production (Figure 8).
Effects of HGF and H2O2/LY 294002 on Rac-1 activationFigure 2
Effects of HGF and H2O2/LY 294002 on Rac-1 activa-
tion. Serum-starved cells was pretreated with or without 
H2O2 (100 μM) for 30 min and then treated with or without 
10 ng/ml HGF (A). Rac-1 dominant positive cells (Q61L) 
were treated with or without HGF (B). After incubation for 
15 min, the cells were collected, washed, and then sonicated. 
Cell lysates were immunoprecipitated with PAK-1 PBD and 
Rac-1 activation was measured by Western blotting with a 
Rac-1 antibody. Representative data from three independent 
experiments were shown.
Effects of HGF and LY 294002 on Rac-1 activationFigure 3
Effects of HGF and LY 294002 on Rac-1 activation. 
Serum-starved cells was pretreated with or without LY (10 
μM) for 30 min and then treated with or without HGF. After 
incubation for 15 min, the cells were collected, washed, and 
then sonicated. Cell lysates were immunoprecipitated with 
PAK-1 PBD and Rac-1 activation was measured by Western 
blotting with a Rac-1 antibody. Representative data from 
three independent experiments were shown.
Effects of HGF or LY 294002 on Akt phosphorylationFigure 4
Effects of HGF or LY 294002 on Akt phosphorylation. 
Serum-starved cells were treated with increasing concentra-
tions of HGF for 15 min. The protein levels of Akt and phos-
pho-Akt were measured by Western blot analysis (A). 
Serum-starved cells were pretreated with LY 294002 (10 
μM) for 30 min and then treated with HGF (10 ng/ml). After 
incubation for 15 min, the protein levels of Akt and phospho-
Akt were determined by Western blot analysis (B). Repre-
sentative data from three independent experiments are 
shown.
Effects of LY 294002 on ROS accumulationFigure 5
Effects of LY 294002 on ROS accumulation. Serum-
starved cells were pretreated with LY 294002 (10 μM) for 30 
min and then treated with HGF (10 ng/ml). The intensity of 
DCF fluorescence was measured with flow cytometry (A). 
Mean fluorescence intensity was obtained from 3 independ-
ent experiments and plotted (B). Representative data from 
three independent experiments are shown. Values are the 
means ± SD of three independent experiments. Statistical 
significance was estimated by Student's t-test (*, p < 0.05; **; 
p < 0.01).Page 4 of 9
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To examine the effects of HGF/c-Met-mediated uPA
induction on the invasive properties of tumor cell pheno-
types, we performed an in vitro invasion assay using a
matrigal migration chamber. The invasiveness of HGF-
treated cells was 2.7-fold higher in NUGC-3 cells, and 1.8-
fold higher in the MKN-28 cells than in the untreated
cells. We hypothesized that HGF-mediated uPA upregula-
tion is responsible for the invasive properties of tumor cell
phenotypes, and consequently blocking uPA activity
could be a potential target in inhibiting tumor cell inva-
sion. To test this hypothesis, we studied the effects of NAC
on tumor cell invasiveness, and showed that invasiveness
of NAC- treated cells was 50% lower in NUGC-3 cells and
90% lower in the MKN-28 cells than in the untreated cells.
When we co-treated with exogenous HGF and NAC, cell
invasion was also decreased. The fact that the invasive
properties of these cells can be inhibited by NAC suggests
that the regulation of ROS may be useful for a therapeutic
target to halt metastasis in stomach cancers (Figure 9).
Effect of H2O2 on ERK and p38 activation induced by HGF
To demonstrate the effect of H2O2 on HGF-mediated ERK
and p38 activation, we treated both cells with H2O2. Treat-
ment with H2O2 increased the activity of ERK and p38.
When cells were treated with H2O2 and HGF together, the
activation of ERK and p38 kinase was decreased (Figure
10).
Effect of ERK and p38 inhibitor on H2O2-induced uPA 
expression
To test whether ERK and p38 activation was involved in
H2O2-mediated uPA secretion, cells were pretreated with
PD 098059 or SB 203580, and uPA secretion was meas-
ured by Western blotting. Both cells showed that H2O2-
mediated uPA secretion was reduced with increasing con-
centrations of PD 098059. Densitometric analysis indi-
cated that 10 μM PD 098059 reduced the urokinase
secretion > 50%. In contrast, pretreatment with SB
203580 increased uPA secretion. These results suggested
that H2O2-mediated uPA secretion and the augmentation
of this activity was regulated by ERK and p38 activation
(Figure 11).
Effects of H2O2 on the levels of HGF mRNAFigure 6
Effects of H2O2 on the levels of HGF mRNA. Cells 
were serum-starved and treated with increasing concentra-
tions of H2O2 (0, 100, 200, and 500 μM). The expression 
level of HGF was measured by real-time RT-PCR. Values are 
the means ± SD of three independent experiments.
Level of expression of HGF after treatment with H2O2 and/or HGFFigure 7
Level of expression of HGF after treatment with 
H2O2 and/or HGF. Cells were serum-starved and treated 
with H2O2 (100 μM) and/or HGF (10 ng/ml). The level of 
HGF mRNA was measured by real-time RT-PCR analysis. 
Values are the means ± SD of triplicates of three independ-
ent experiments. Statistical significance was estimated by Stu-
dent's t-test (*, p < 0.05;**, p < 0.01).
Effects of H2O2 and NAC on HGF-mediated upregulation of uPAFigure 8
Effects of H2O2 and NAC on HGF-mediated upregu-
lation of uPA. Serum-starved cells were pretreated with or 
without H2O2 (100 μM) and NAC (5 mM) for 30 min, and 
then treated with or without HGF (10 ng/ml). After incuba-
tion for 24 h, uPA secreted in culture media was measured 
by Western blot analysis with a uPA antibody. Representa-
tive data from 3 independent experiments were shown.Page 5 of 9
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ERK1/2 phosphorylation
To investigate the possibility of an interaction between
ERK and p38 activation in H2O2-mediated uPA expres-
sion, the effect of SB 203580 on ERK activation was meas-
ured. Pretreatment with SB 203580 increased ERK
phosphorylation in the H2O2-treated cells. Co-treatment
with PD 098058 and SB 203580 decreased ERK phospho-
rylation. These results suggested that H2O2-mediated uPA
secretion and the augmentation of this activity were regu-
lated by ERK activation, and p38 activation might indi-
rectly affect H2O2-mediated uPA secretion. In other
words, the increments of H2O2-mediated uPA secretion
and its level of expression according to the treatment by
SB 203580 were mediated through ERK activation (Figure
12).
Discussion
An abundance of evidence indicates the ROS play a central
role in the key intracellualar signal transduction pathway
for a variety of cellular process [11,12]. Aberrant ROS sig-
naling may result in physiologic and pathologic changes,
such as cell cycle progression [13], apoptosis, and aging
[14]. Previously, elevated oxidative status has been found
in many types of cancer cells, which contribute to carcino-
genesis [15]. Recently, the involvement of ROS signaling
in tumor metastasis was highlighted [16,17]. More evi-
dence indicated that metastasis of tumor cells was closely
associated with the microenvironment around the pri-
mary tumor lesions in which the growth factors and
cytokines, such as transforming growth factor-β (TGF-β)
and HGF, support malignant growth, invasion, and dis-
semination of the primary tumor [18]. Several important
signal transduction pathways, such as MAPK, PI3K, and
the Rho-GTPase cascades, are known to mediate transcrip-
tional regulation of metastasis-related genes, such as
MMPs [19]. Importantly, ROS are closely associated with
these signal cascades, strongly implicating the involve-
ment of ROS in tumor progression.
Effects of NAC on in vitro invasivenessFigure 9
Effects of NAC on in vitro invasiveness. Cells in RPMI 
1640 media supplemented with 5% FBS were placed in the 
upper chamber of Matrigel chamber and treated with or 
without NAC. The bottom chamber was filled with media 
containing 5% FBS and HGF with or without NAC. After 48 
h of incubation, the cells which migrated through the filter 
were counted under light microscopy (10 fields at 200× 
power). Values are the means ± SD of triplicates of three 
independent experiments. Statistical significance was esti-
mated by Student's t-test (*, P < 0.05; **, p < 0.01).
Effects of H2O2 on ERK and p38 activation induced by HGFFigure 10
Effects of H2O2 on ERK and p38 activation induced by 
HGF. Serum-starved cells were pretreated with or without 
H2O2 (100 μM) for 30 min and then treated with or without 
HGF (10 ng/ml). After incubation for 15 min, the levels of 
phosphorylated ERK, ERK, phosphorylated p38, and p38 
were measured by Western blot analysis. Representative 
data from 3 independent experiments are shown.
Effects of PD 98059 or SB 203580 on HGF-mediated up-reg-ulation f uPAFigure 11
Effects of PD 98059 or SB 203580 on HGF-mediated 
up-regulation of uPA. Serum-starved cells were pre-
treated with or without H2O2 (100 μM) for 30 min and then 
treated with PD 98059 (5, 10 and 20 μM) or SB 203580 (1, 5 
and 10 μM). After incubation for 24 h, uPA in culture media 
was measured by Western blot analysis. Representative data 
from 3 independent experiments were shown.Page 6 of 9
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ROS production within cells under hypoxia/re-oxygena-
tion circumstances [20]. Rac-1 belongs to the rho family
of small GTP-binding proteins and its role in the produc-
tion of ROS in phagocytic cells, such as neutrophils, is
well-established [21]. In such cells, Rac proteins are essen-
tial for the assembly of the plasma membrane NADPH
oxidase, which is responsible for the transfer of electrons
to molecular oxygen, leading to the production of super-
oxide anions. Rac-1-regulated ROS have been implicated
in a variety of cellular process, including growth, migra-
tion, and transformation [22,23].
HGF is a prototypical prosurvival growth factor and also
known to prevent non-transformed hepatocytes from oxi-
dant-mediated apoptosis [24]. Ozaki et al. demonstrated
that HGF-stimulated activation of pI3K-AKT is necessary
and sufficient to suppress intracellular oxidative stress and
apoptosis by inhibiting activation of pro-apoptotic, pro-
oxidative Rac-1 GTPase [25]. In our study, we showed
HFG decreased Rac-1 protein and ROS production, and
intracellular ROS production increased when treated with
the PI3-kinase inhibitor, LY294002. Miura et al have
already reported that ROS promote rat ascites hepatoma
cell invasion beneath mesentery-derived mesothelial cell
monolayers. To investigate the mechanisms for this, they
examined the involvement of HGF. The rat ascites
hepatoma cell line, AH109A, expresses HGF and c-Met
mRNAs. Treatment with ROS augments the amount of
HGF mRNA in AH109A and the HGF concentration in the
medium. ROS also induces HGF gene expression in mes-
othelial cells. Exogenously-added HGF enhances the inva-
sive activity of AH109A cells. Pretreatment with ROS
shows increased invasive activity, which is blocked by
simultaneous pretreatment with anti-HGF antibody.
These results suggest that the invasive activity of AH109A
is mediated by autocrine and paracrine pathways of HGF,
and ROS potentiate invasive activity by inducing gene
expression of HGF in AH109A and mesothelial cells [26].
In our study, 100 μM H2O2 increased HGF gene expres-
sion. When we co-treated with exogenous HGF and H2O2,
it showed downregulation of HGF gene expression.
The overexpression of uPA has been detected in various
malignancies, including breast [27,28] and colon cancers
[29]. Some dates have shown that a high level of uPA in
tumors is associated with a rapid disease progression and
a poor prognosis [30,31]. Miyazono et al. [32] showed
oxidative stress induces uPA in RC-K8 human malignant
lymphoma cells and H69 human small cell lung carci-
noma cells. Kim et al. reported that ROS precedes the
induction of uPAR expression, and this upregulation is
attenuated by NAC, a ROS scavenger. In addition, exoge-
nous ROS alone induced the expression and promoter
activity of uPA [33]. Our study showed similar results with
the above studies. Exogenous H2O2 increased uPA pro-
duction and inhibited uPA after treatment of NAC.
Two of the candidate signaling molecules involved in
EMT and cell migration are protein kinase C- (PKC) and
MAP kinase-mediated signal pathways, which coordinate
complex physiologic and pathologic events, including cell
cycle control, differentiation, neo-angiogenesis, and
metastasis [34]. Cytokines, such as TGF-β, HGF, and
fibroblast growth factor, may stimulate tumor invasion
metastasis via PKC and MAP kinase [35]. Mechanisms by
which ROS affect signal transduction and gene expression
have been described; some works have shown that ROS
can activate MAPK, including ERK and p38 kinase. Mean-
while, serine and threonine protein kinase AKT is also reg-
ulated by exogenous and endogenous ROS [36,37]. How
MAP kinase is activated by ROS to trigger cell migration is
not clear. Protein kinase may be activated by ROS for a
variety of cellular effects. Moreover, protein kinase is also
an upstream kinase of MAPK required for cell migration
[38]. Wu et al. [39] found ROS plays a central role in
mediating PKC and ERK signaling for regulation of gene
expression of integrins and E-cadherin that are responsi-
ble for EMT and migration of the human hepatoma cell
line, HepG2. Lee et al. [40] examined the role of the MAP
kinase signaling pathway on the stimulation of uPA syn-
thesis in gastric cancer cells by using HGF. They showed
that the phosphorylation of ERK and p38 kinase are
dependent on the dosage of HGF and also clarified that
uPA secretion and zymoactivity in the NUGC-3 cell lines
were stimulated with HGF, which suggests the involve-
ment of ERK and p38 kinase in the HGF-mediated uPA
Effects of PD 98059 and/or SB 203580 on H2O2-induced ERK phosph rylationFigure 12
Effects of PD 98059 and/or SB 203580 on H2O2-
induced ERK phosphorylation. Serum-starved cells were 
pretreated with PD 98059 (10 μM) and/or SB 203580 (1 and 
5 μM) for 30 min and then treated with HGF (10 ng/ml) for 
15 min. ERK activation was evaluated by Western blot analy-
sis. Representative data from 3 independent experiments are 
shown.Page 7 of 9
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measured in order to clarify which signaling pathway,
between the ERK and p38 kinase pathways, plays the
more important role in H2O2-induced uPA secretion.
Increments of H2O2-mediated uPA expression via SB
203580 pretreatment were shown to be mediated by ERK
activation, indicating that p38 kinase functions as a nega-
tive growth regulator. Xian et al. [41] also reported similar
results in the PCNC-1 pancreatic cancer cell line.
In this study, we showed that HGF decreased intracellular
ROS and increased the uPA protein levels. Treatment with
H2O2 also increased HGF mRNA and uPA protein. How-
ever, co-treatment with HGF and H2O2 decreased uPA,
and HGF mRNA and protein levels increased by H2O2
treatment. These results suggest that exogenous HGF
might play a negative role in the regulation of uPA protein
levels increased by H2O2 treatment (Figure 13). Thus, fur-
ther study is necessary to elucidate by which mechanism
exogenous HGF regulates uPA protein levels through the
regulation of intracellular ROS levels and signal pathways.
Overall, these results suggest that ROS are involved uPA
regulation in control of tumor invasion and metastasis by
cytokines, such as HGF in gastric cancer cells. Notwith-
standing the above limitation, evidence that ROS directly
contributes to HGF/c-Met-dependant tumor invasion and
metastasis opens a novel perspective in the complex cor-
relation between oxygen radicals and malignancy, and
suggests new possibilities of antioxidant-based therapeu-
tic intervention, complementary to the search for HGF/c-
Met inhibitory compounds.
Competing interests
The authors declare that they have no competing interests.
Authors' contributions
KHL carried out cell treatment, cell transfection, immuno-
blotting analysis and drafted the manuscript. SWK partic-
ipated in the design of the study, coordination and
performed the statistical analysis. JRK supervised experi-
mental work. All authors read and approved the final
manuscript.
Acknowledgements
This work was supported by the Korea Science and Engineering Foundation 
(KOSEF) NCRC grant funded by the Korea government (MEST: R15-2004-
033-05001-0), and by the KOSEF MRC grant funded by the MEST (R13-
2005-005-01001-0).
References
1. Halliwell B, Gutteridge JMC: Antioxidant defences.  In Free radicals
in biology and medicine New York, NY: Oxford University Press; 1999. 
2. Janssen AML, Bosman CB, Kruidenier L, Griffioen G, Lamers CBHV,
Van Krieken JHJM, Velde CJH Van de, Verspaget HW: Superoxide
dismutase in the human colorectal canter sequence.  Journal
of Cancer Research and Clinical Oncology 1999, 125:327-335.
3. Bottaro DP, Rubin JS, Faletto DL, Chan AM, Kmiecik TE, Woude GF
Vande, Aaronson SA: Identification of the hepatocyte growth
factor receptor as the c-met proto-oncogene product.  Sci-
ence 1991, 251:802-804.
4. Bowers DC, Fan S, Walter KA, abounader R, Williams JA, Rosen EM,
Laterra J: Scatter factor/hepatocyte growth factor protects
against cytotoxic death in human glioblastoma via phos-
phatidylinositol 3-kinase-and AKT-dependent pathways.
Cancer Res 2000, 60:4277-4283.
5. Di Renzo MF, Olivero M, Giacomini A, Porte H, Chastre E, Mirossay
L, Nordinger B, Bretti S, Bottardi S, Giordano S, Plebano M, Gespach
C, Comoglio PM: Overexpression and amplification of the met/
HGF receptor gene during the progression of colorectal can-
cer.  Clin Cancer Res.  1995, 1(2):147-154.
6. Restuccia C, Angeluccl A, Gravlna GL, Villanova I, Teti A, Albini A,
Bologna M: Osteoblast-derived TGF-beta1 modulates matrix
degrading protease expression and activity prostate cancer
cells.  Int J Cancer 2000, 85:407-15.
7. Lee KH, Hyun MS, Kim JY: Invasion-Metastasis by Hepatocyte
Growth Factor/c-Met Signaling Concomitant with Induction
of Urokinase plasminogen Activator in Human Pancreatic
Cancer: Role as Therapeutic Target.  Cancer Research Treatment
2003, 35:207-12.
8. English J, Pearson G, Wilsbacher J, Swantek J, Karandikar M, Xu S,
Cobb MH: New insights into the control of MAP kinase path-
ways.  Exp Cell Res 1999, 253:255-70.
9. Widmann C, Gibson S, Harpe MB, Johnson GL: Mitogen-activated
protein kinase: conservation of a three-kinase module from
yeast to human.  Physiol Rev 1999, 79:143-80.
10. Gupta A, Rosenberger SF, Bowden GT: Increased ROS levels con-
tribute to elevated transcription factor and MAP kinase
activities in malignantly progressed mouse keratinocyte cell
lines.  Carcinogenesis 1999, 20:2063-2073.
11. Aslan M, Azben T: Oxidants in receptor tyrosine kinase signal
transduction pathways.  Antioxid Redox Signal.  2003, 5(6):781-788.
12. Chiarugi P: The redox regulation of LMW-PMP during cell
proliferation or growth inhibition.  IUBMB Life 2001, 52:55-59.
13. Boonstra J, Post JA: Molecular events associated with reactive
oxygen species and cell cycle progression in mammalian
cells.  Gene 2004, 337:1-13.
14. Gourlay CW, Ayscough KR: The actin cytoskeleton: A key reg-
ulator of apoptosis and ageing? Nature Reviews.  Molecular Cell
Biology 2005, 6:583-589.
15. Toyokumi Winter S: Reactive oxygen species-induced molecu-
lar damage and its application in pathology.  Pathology Interna-
tional 1999, 49:91-102.
Interaction of exogenous HGF with H2O2 in uPA expressionFigure 13
Interaction of exogenous HGF with H2O2 in uPA 
expression.Page 8 of 9
(page number not for citation purposes)
Journal of Experimental & Clinical Cancer Research 2009, 28:73 http://www.jeccr.com/content/28/1/73Publish with BioMed Central   and  every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
16. Radisky DC, Levy DD, Littlepage LE, Liu HH, Nelson CM, Fata JE,
Leake D, Godden EL, Albertson DG, Nieto MA, Werb Z, Bissell MJ:
Rac lb and reactive oxygen species mediate MMP-3-induced
EMT and genomic instability.  Nature 2005, 436:123-127.
17. Chambers AF, Groom AC, MacDonald IC: Dissemination and
growth of cancer cells in metastatic sites. Nature Reviews.
Cancer 2002, 2:563-572.
18. Kassis J, Klominek J, Kohn EC: Tumor microenvironment: What
can ffusions teach us?  Diagnostic Cytopathology 2005, 33:316-319.
19. Melson KK, Melendez JA: Mitochondrial redox control of matrix
metalloproteinases.  Free Radical Biology & Medicine 2004,
37:768-784.
20. Ozaki Deshpande SS, Angkow P, Bellan J, Lowenstein CJ, Dinauer MC,
Goldschmidt Clermont PJ, lrani K: Inhibition of the Rac1 GTPase
protects against nonlethal ischemia/reperfusion-induced
necrosis and apoptosis in vivo.  FASEB J 2000, 14:418-429.
21. Faris SL, Rinckel LA, Huang J, Hong YR, Kleinberg ME: Phagocyte
NADPH oxidase p67-phox possesses a novel carboxyl termi-
nal binding site for the GTPases Rac 2 and Cdc42.  Biochem Bio-
phys Res Commun 1998, 247:271-276.
22. Yeh LH, Park YJ, Hansalia RJ, Ahmed IS, Deshpande SS, Goldschmidt
Clemont PJ, Irani K, Alevriadou BR: Shear-induced tyrosine phos-
phorylation in endothelial cells requires Rac1-dependent
production of ROS.  AM J Physiol 1999, 276:C838-C847.
23. Wang Z, Castresana MR, Newman WH: Reactive oxygen and NF-
kappa B in VEGF-induced migration of human vascular
smooth muscle cells.  Biochem Biophys Res Commun 2001,
285:669-674.
24. Kosai K, Matsumoto K, Funakoshi H, Nakamura T: Hepatocyte
growth factor prevents endotoxin-induced lethal hepatic
failure in mice.  Hepatology 1999, 30:151-159.
25. Ozaki M, Haga S, Zhang HG, lrani K, Suzuki S: Inhibitions of
hypoxia/reoxygenation-induced oxidative stress in HGF-
stimulated anti-apoptotic signaling: role of PI3-K and Akt
kinase upon rac1.  Cell Death and Differentiation 2003, 10:508-515.
26. Miura Y, Kozuki Y, Yagasaki K: Potentiation of invasive activity
of hepatoma cells by reactive oxygen species is mediated by
autocrine/paracrine loop of hepatocyte growth factor.  Bio-
chem Biophys Res Commun 2003, 305:160-165.
27. Xing RH, Rabbani SA: Overexpression of urokinase receptor in
breast cancer cells result in increased tumor invasion,
growth and metastasis.  Int J Cancer 1996, 67:423-9.
28. Duggan C, Maguire T, McDermott E, O'Higgins N, Fennelly JJ, Duffy
MJ: Urokinase plasminogen activator and urokinase plas-
minogen activator receptor in breast cancer.  Int J Cancer 1995,
61:597-600.
29. Yang JL, Seetoo DG, Wang Y, Ranson M, Bemey CR, Ham JM, Russell
PJ, Crowe PJ: Urokinase-type plasminogen activator and its
receptor in colorectal cancer: independent prognostic fac-
tors of metastasis and cancer-specific survival and potential
therapeutic targets.  Int J Cancer 2000, 20:431-9.
30. Solomayer EF, Kiel IJ, Wallwlener D, Bode S, Meyberg G, Sillem M,
Gollan CH, Kramer MD, Krainick U, Baster G: Prognostic rele-
vance of urokinase plasminogen activator detection in
micrometastatic cells in the bone marrow of patients with
primary breast cancer.  Br J Cancer 1997, 76:812-8.
31. Bouchetm C, Spyratos F, Hacène K, Furcos L, Bécette V, Oglobine J:
Prognostic value of urokinase plasminogen activator in pri-
mary breast carcinoma: comparison of two immunoassay
methods.  Br J Cancer 1998, 77(9):1495-501.
32. Miyazono T, Niiya K, Kiguchi T, Sakuragawa N, Harada M, Watanabe
A: Oxidative stress induces urokinase-type plasminogen acti-
vator in RC-K8 human malignant lymphoma cells and H69
human small cell lung carcinoma cells.  Fibrinolysis Proteolysis
2000, 14:366-73.
33. Kim MH, Yoo HS, Kim MY, Jang HJ, Baek MK, Kim HR, Kim KK, Shin
BA, Ahn BW, Jung YD: Helicobacter pylori stimulates uroki-
nase plasminogen activator receptor expression and cell
invasiveness through reactive oxygen species and NF-kB sig-
naling in human gastric carcinoma cells.  Int J Mol Med 2007,
19(4):689-697.
34. Hofmann J: Protein kinase C isohyets as potential targets for
anticancer therapy.  Curr Cancer Drug Targets 2004, 4:125-46.
35. Lee KH, Hyun MS, Kim JR: Growth factor-dependent activation
of the MAPK pathway in human pancreatic cancer: MEK/
ERK and p38 MAP kinase interactionin uPA synthesis.  Clin
Exp Metastasis 2003, 20:499-505.
36. Gupta A, Rosenberger SF, Bowden GT: Increased ROS levels con-
tribute to elevated transcription factor and MAP kinase
activities in malignantly progressed mouse keratinocyte cell
lines.  Carcinogenesis 1999, 20:2063-2073.
37. Klotz LO, Pellieux C, Briviba K, Pierlot C, Aubry JM, Sies H:
Mitogen-activated protein kinase (p38-, JNK-, ERK-) activa-
tion pattern induced by extracellular and intracellular sin-
glet oxygen and UVA.  Eur J Biochem 1999, 260:917-922.
38. Kenmorgant S, Zicha D, Parker PJ: PKC controls HGF-dependent
c-Met traffic, signaling and cell migration.  EMBO Journal 2004,
23:3721-3734.
39. Wu W-S, Tsai RK, Chang CH, Wang S, Wu J-R, Chang Y-X: Reactive
Oxygen Species Mediated Sustained Activation of Protein
Kinase C and Extracellular Signal-Regulated Kinase for
Migration of Human Hepatoma Cell HepG2.  Mol Cancer Res
2006, 4(10):747-58.
40. Lee KH, Choi EY, Kim MK, Hyun MS, Jang BI, Kim TN, Kim SW, Song
SK, kim JH, Kim J-R: Regulation of hepatocyte growth factor-
mediated urokinase plasminogen activator secretion by
MEK/ERK activation in human stomach cancer cell lines.  Exp
Mol Med 2006, 38(1):27-35.
41. Xian ZD, Thomas EA: MEK/ERK-mediated proliferation is neg-
atively regulated by P38 MAP kinase in the human pancre-
atic cancer cell line, PANC-1.  Biochem Biophy Res Commun 2001,
282:447-53.Page 9 of 9
(page number not for citation purposes)
